PFIZER TO REPATRIATE $8.6 BILLION IN FOREIGN EARNINGS

The board of directors of Pfizer Inc today approved the repatriation, pursuant to the American Jobs Creation Act of 2004, of an additional $8.6 billion in foreign earnings beyond the initial $28.3 billion previously announced by the company. "Through our repatriation of foreign earnings this year, we are strengthening Pfizer's ability to pursue strategic opportunities while enhancing the company's flexibility to invest in our R&D pipeline and new product potential in the U.S.," said Hank McKinnell, chairman and chief executive officer.

BioSpace (http://www.biospace.com/news_story.cfm?StoryID=20441120&full=1)